Searchable abstracts of presentations at key conferences in endocrinology

ea0063p590 | Diabetes, Obesity and Metabolism 2 | ECE2019

Are all hypoglycemic drugs similar for men with type 2 diabetes and testosterone deficiency?

Khripun Irina , Vorobyev Sergey , Petrovskaya Ekaterina , Kuzmenko Natalia

Background: To date, it has been established that appointment of testosterone replacement therapy (TRT) in men with type 2 diabetes mellitus (T2DM) and testosterone (T) deficiency improves control of carbohydrate metabolism. Although, studies of effectiveness of different hypoglycemic drugs in men with T2DM and T deficiency have not been conducted. The aim of this study was to compare the efficacy of various types of hypoglycemic therapy in patients with T2DM and late onset hy...

ea0070aep847 | Reproductive and Developmental Endocrinology | ECE2020

Psychological status and quality of life in men with hypogonadism and type 2 diabetes mellitus, receiving testosterone replacement therapy

Khripun Irina , Vorobyev Sergey , Kuzmenko Natalia , Petrovskaya Ekaterina

It is known that the presence of type 2 diabetes mellitus (T2DM) deteriorates the psychological status of patients, but its combination with a deficiency of testosterone (T) in men is not well studied. The aim of this work was to study the effect of T replacement therapy (TRT) on the levels of anxiety, depression, symptoms of androgen deficiency, diabetes and quality of life in men with T2DM and functional hypogonadism.Materials and methods: We examined ...

ea0049ep695 | Obesity | ECE2017

Characteristics of cellular immunity in men with obesity and hypogonadism

Dzantieva Elizaveta , Khripun Irina , Gusova Zalina , Vorobiev Sergey , Allakhverdieva Yanina , Kuzmenko Natalia , Petrovskaya Ekaterina

Abstract: There are few studies of the cellular immunity in men with obesity and hypogonadism. The aim was to study the parameters of cellular components of the immune system in patients with obesity and hypogonadism.Materials and methods: The study included 120 men aged 40–65 years with obesity (mean BMI – 35±5.6 kg/m2). Patients were divided into two groups depending on the level of total testosterone (T). The first group incl...